Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

J&j Innovative Medicine recalls IMAAVY (nipocalimab-aahu) Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Presence of particulate matter.
Products
  • IMAAVY (nipocalimab-aahu) Injection
Company
J&j Innovative Medicine
Where it was sold

OH

States: Ohio

Units affected
49 vials
About this recall
IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01